Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · Alps

SBIO Holdings: What ALPS Medical Breakthroughs ETF Owns

Ticker SBIO · · Holdings as of May 31, 2026

Expense ratio
0.5%$50/yr per $10k
5-yr return
+0.7%annualized
1-yr return
+54.2%as of Dec 2025
Net assets
$161.8Mall share classes
Holdings
89

Bottom line

What does SBIO hold?

SBIO held 89 positions as of May 31, 2026. Its largest holding is Alkermes Plc at 4.48% of the fund, and the top 10 positions add up to 34.8%. By asset type it is 100% stocks.

Updated Jul 29, 2026

SBIO top 25 holdings

#HoldingType% of fundValue
1 Alkermes Plc
Alkermes PLC
Stocks 4.48%$7.2M
2 Kymera Therapeutics Inc
Kymera Therapeutics, Inc.
Stocks 4.23%$6.9M
3 Celcuity Inc
Celcuity, Inc.
Stocks 3.92%$6.3M
4 Mirum Pharmaceuticals Inc
Mirum Pharmaceuticals, Inc.
Stocks 3.90%$6.3M
5 Spyre Therapeutics Inc
Spyre Therapeutics, Inc.
Stocks 3.68%$6.0M
6 Cg Oncology Inc
CG oncology, Inc.
Stocks 3.35%$5.4M
7 Apogee Therapeutics Inc
Apogee Therapeutics, Inc.
Stocks 2.93%$4.7M
8 Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals, Inc.
Stocks 2.90%$4.7M
9 Travere Therapeutics Inc
Travere Therapeutics, Inc.
Stocks 2.77%$4.5M
10 Dianthus Therapeutics Inc
Dianthus Therapeutics, Inc.
Stocks 2.64%$4.3M
11 Newamsterdam Pharma Co Nv
Newamsterdam Pharma Co. NV
Stocks 2.47%$4.0M
12 Viking Therapeutics Inc
Viking Therapeutics, Inc.
Stocks 2.41%$3.9M
13 Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals, Inc.
Stocks 2.37%$3.8M
14 Acadia Pharmaceuticals Inc
ACADIA Pharmaceuticals, Inc.
Stocks 2.35%$3.8M
15 Edgewise Therapeutics Inc
Edgewise Therapeutics, Inc.
Stocks 2.33%$3.8M
16 Denali Therapeutics Inc
Denali Therapeutics, Inc.
Stocks 2.13%$3.4M
17 Oruka Therapeutics Inc
Oruka Therapeutics, Inc.
Stocks 1.81%$2.9M
18 Structure Therapeutics Inc
Structure Therapeutics, Inc.
Stocks 1.78%$2.9M
19 Disc Medicine Inc
Disc Medicine, Inc.
Stocks 1.69%$2.7M
20 Ideaya Biosciences Inc
Ideaya Biosciences, Inc.
Stocks 1.65%$2.7M
21 Vera Therapeutics Inc
Vera Therapeutics, Inc.
Stocks 1.61%$2.6M
22 Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals, Inc.
Stocks 1.61%$2.6M
23 Relay Therapeutics Inc
Relay Therapeutics, Inc.
Stocks 1.60%$2.6M
24 Mineralys Therapeutics Inc
Mineralys Therapeutics, Inc.
Stocks 1.59%$2.6M
25 Celldex Therapeutics Inc
Celldex Therapeutics, Inc.
Stocks 1.33%$2.2M

Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026

Asset mix

Stocks100.0%

Country exposure

BE1.2%
CA2.9%
CH0.8%
GB1.1%
IE4.5%
KY4.7%
NL4.7%
US80.2%